Results 221 to 230 of about 195,947 (275)

Can letrozole be repurposed for the treatment of visceral leishmaniasis? [PDF]

Antimicrob Agents Chemother
Ribeiro JM, Teixeira EdM, Alves LL, Alves ÉAR, Pascoal-Xavier MA, Santi AMM, Oliveira E, Guimarães PPG, Teixeira-Carvalho A, Murta SMF, Peruhype-Magalhães V, Souza-Fagundes EM.   +11 more
europepmc   +1 more source

Visceral leishmaniasis mimicking inflammatory myositis that led to haemophagocytic lymphohistiocytosis. [PDF]

BMJ Case Rep
Ibad IK, Vankayala A, Manwatkar A, Mathew J.   +3 more
europepmc   +1 more source

Efficacy of 4 % deltamethrin-impregnated collars against canine visceral leishmaniasis across different areas and the sociocultural burden of collar loss in a middle-income country. [PDF]

One Health
Matsumoto PSS, Rampazzi KLS, Camprigher VM, Taniguchi HH, Pereira VBR, Hiramoto RM, de Raeffray Barbosa JE, Neto RAP, Ressio RA, da Silva Batista LF, de Barros Cortez LRP, Rahaman KR, Novak M, Tolezano JE.   +13 more
europepmc   +1 more source

Ontogeny-independent expression of LPCAT2 in granuloma macrophages during experimental visceral leishmaniasis

Dey S, Cao J, Balluff B, Dey NS, Gilbert L, James S, Dowle AA, Calder G, O’Toole P, Heeren RMA, Kaye PM.   +10 more
europepmc   +1 more source

Some of the next articles are maybe not open access.

Related searches:

Efficacy and safety of Pentamidine isethionate for tegumentary and visceral human leishmaniasis: a systematic review.

Journal of Travel Medicine, 2021
RATIONALE FOR REVIEW We performed a systematic review of the literature to investigate the efficacy and safety of pentamidine isethionate for the treatment of human visceral and tegumentary leishmaniasis.
Matteo Piccica, F. Lagi, A. Bartoloni, L. Zammarchi   +3 more
semanticscholar   +1 more source

VISCERAL LEISHMANIASIS

Gastroenterology Clinics of North America, 1996
Visceral leishmaniasis presents a serious problem in endemic regions that is difficult to treat or prevent. Several epidemiologic problems make the disease particularly troublesome to manage. These include the facts that classic visceral leishmaniasis is fatal if untreated and there is not reliable access to medical care in many endemic regions.
M E, Wilson, J A, Streit
openaire   +3 more sources

Hamster, a close model for visceral leishmaniasis: Opportunities and challenges

Parasite immunology (Print), 2020
Visceral leishmaniasis (VL) caused by parasites belonging to genus Leishmania (L.) is classified as a category I disease by the TDR/WHO. The understanding of the pathogenesis of this disease was built from the findings of available experimental models ...
S. Saini, A. Rai
semanticscholar   +1 more source